High levels of factor VIII (FVIII) but not von Willebrand factor (vWF) are
known to increase the risk for venous thromboembolism, Whether high FVIII l
evels originate from hereditary defects or from acquired conditions remains
unanswered. The objective of our study was to investigate whether there is
evidence for familial clustering of elevated FVIII levels in families in w
hich greater than or equal to1 member has been affected by a thromboembolic
event and had reproducibly high FVIII levels. We investigated FVIII levels
in 361 patients with previous venous thromboembolism. FVIII levels were me
asured by a chromogenic assay; the cutoff value was defined as the 98th per
centile of FVIII plasma levels of 266 blood donors. vWF levels were determi
ned by an enzyme immunoassay. After exclusion of known causes of FVIII elev
ation, such as the acute thrombotic event itself; inflammation; malignancy;
liver, renal, or vascular disease; surgery; or pregnancy, we included 17 p
atients with unexplained, reproducibly high FVIII levels. The investigation
was also extended to these patients' relatives. Multiple regressive analys
is of blood donors and asymptomatic family members showed that the affiliat
ion with a family in which 1 member suffered from venous thromboembolism an
d had reproducibly high FVIII levels is the second most important predictor
for FVIII levels. Familial clustering was analyzed by the Houwing-Duisterm
aat familial aggregation test. After adjustment for the influence of age, s
ex, blood group, and vWF, FVIII levels were significantly (P=0.038) cluster
ed within families. In conclusion, FVIII levels seem to be familially deter
mined in families in which a member showed high FVIII levels after previous
venous thromboembolism.